HLF Stock - Herbalife Nutrition Ltd.
Unlock GoAI Insights for HLF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.99B | $5.06B | $5.20B | $5.80B | $5.54B |
| Gross Profit | $3.89B | $3.87B | $4.03B | $4.56B | $4.39B |
| Gross Margin | 77.9% | 76.5% | 77.4% | 78.6% | 79.2% |
| Operating Income | $385.90M | $356.40M | $545.20M | $734.10M | $640.60M |
| Net Income | $254.30M | $142.20M | $321.30M | $447.20M | $372.60M |
| Net Margin | 5.1% | 2.8% | 6.2% | 7.7% | 6.7% |
| EPS | $2.53 | $1.44 | $3.26 | $4.22 | $2.83 |
Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and rest of Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which comprise functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products, including N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that comprise start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 26th 2025 | Argus | Upgrade | Buy | - |
| March 21st 2025 | DA Davidson | Upgrade | Buy | $14← $7.5 |
| August 1st 2024 | B. Riley Securities | Reiterated | Buy | $17← $16 |
| September 14th 2023 | DA Davidson | Initiation | Neutral | $13.5 |
| June 7th 2023 | Mizuho | Initiation | Neutral | $13 |
| February 3rd 2023 | BofA Securities | Initiation | Underperform | $14 |
| July 12th 2022 | Jefferies | Upgrade | Buy | $26 |
| May 17th 2022 | Argus | Downgrade | Hold | - |
| May 4th 2022 | Jefferies | Downgrade | Hold | $26← $60 |
Earnings History & Surprises
HLFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 18, 2026 | $0.43 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.47 | $0.50 | +6.4% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $0.53 | $0.59 | +11.3% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $0.40 | $0.59 | +47.5% | ✓ BEAT |
Q1 2025 | Feb 19, 2025 | $0.10 | $0.36 | +260.0% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $0.35 | $0.57 | +62.9% | ✓ BEAT |
Q3 2024 | Jul 31, 2024 | $0.43 | $0.54 | +25.6% | ✓ BEAT |
Q2 2024 | May 1, 2024 | $0.37 | $0.49 | +32.4% | ✓ BEAT |
Q1 2024 | Feb 14, 2024 | $0.38 | $0.28 | -26.3% | ✗ MISS |
Q4 2023 | Nov 1, 2023 | $0.75 | $0.65 | -13.3% | ✗ MISS |
Q3 2023 | Aug 2, 2023 | $0.69 | $0.74 | +7.2% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $0.65 | $0.54 | -16.9% | ✗ MISS |
Q1 2023 | Feb 14, 2023 | $0.34 | $0.53 | +55.9% | ✓ BEAT |
Q4 2022 | Oct 31, 2022 | $0.80 | $0.91 | +13.7% | ✓ BEAT |
Q3 2022 | Aug 2, 2022 | $0.61 | $0.96 | +57.4% | ✓ BEAT |
Q2 2022 | May 3, 2022 | $0.90 | $0.99 | +10.0% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $0.59 | $0.57 | -3.4% | ✗ MISS |
Q4 2021 | Nov 2, 2021 | $1.06 | $1.21 | +14.2% | ✓ BEAT |
Q3 2021 | Aug 3, 2021 | $1.29 | $1.52 | +17.8% | ✓ BEAT |
Latest News
Citigroup Maintains Buy on Herbalife, Raises Price Target to $17
📈 PositiveMizuho Maintains Neutral on Herbalife, Raises Price Target to $11
➖ NeutralHerbalife shares are trading higher after Argus Research upgraded the stock from Hold to Buy.
📈 PositiveArgus Research Upgrades Herbalife to Buy
📈 PositiveHerbalife Widens FY2025 Sales Guidance from $4.943B-$5.143B to $4.843B-$5.343B vs $4.999B Est
➖ NeutralHerbalife Sees Q4 Sales $1.226B-$1.274B vs $1.252B Est
➖ NeutralHerbalife Q3 Adj. EPS $0.50 Beats $0.46 Estimate, Sales $1.274B Beat $1.266B Estimate
📈 PositiveHerbalife Invests $7M in New California Lab to Boost Quality and Innovation
📈 PositiveFrequently Asked Questions about HLF
What is HLF's current stock price?
What is the analyst price target for HLF?
What sector is Herbalife Nutrition Ltd. in?
What is HLF's market cap?
Does HLF pay dividends?
Similar Stocks
Consumer Defensive SectorExplore stocks similar to HLF for comparison